RayzeBio Alternatives & Competitors

12 companies similar to RayzeBio — Targeted innovative radiopharmaceuticals for cancer

Exelixis

Exelixis works on discovering, developing, and commercializing therapies for the treatment...

1566 IPO $340.26M

Alameda, United States

Biotechnology

NiKang Therapeutics Inc.

37 Series C $260.00M

Wilmington, United States

Biotechnology Health Care

Arcellx

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

224 Acquired $8.43B

Redwood City, United Stat...

Biopharma Biotechnology +3

Crossbow Therapeutics, Inc

Established antibody engineering to target the untapped universe of intracellular cancer t...

45 Series B $157.00M

Cambridge, United States

Biotechnology Health Care +1

Track all RayzeBio competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Alterome Therapeutics, Inc

To Life!

43 Series B $231.00M

San Diego, United States

Biopharma Biotechnology +1

Glycyx

Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...

3 Series A $7.10M

San Francisco, United Sta...

Biopharma Biotechnology +1

Avacta Therapeutics

Expanding the reach of highly potent cancer therapies with the pre|CISION® platform.

44 Post Ipo Equity

London, United Kingdom

Biotechnology Health Care +1

Celyad Oncology

19 Post Ipo Equity $135.80M

Belgium

Biotechnology Health and Wellness +1

Mosaic TX

Resolving cancer's complexity through the power of targeted drug combinations

22 Series A $28.52M

United Kingdom

Biotechnology Health and Wellness

Breakpoint Therapeutics

Modulating DNA damage responses to cure cancer

3 Series Unknown $30.00M

Hamburg, Germany

Biotechnology Health Care +1

KSQ Therapeutics, Inc.

The company is deploying CRISPRomics for novel drug development across broad therapeutic a...

60 Series C $166.00M

Lexington, United States

Biopharma Biotechnology +2

OnCusp Therapeutics

We Bring Oncology Innovation to Life

28 Series A $125.00M

New York, United States

Biotechnology Health Care +1

About RayzeBio

Targeted innovative radiopharmaceuticals for cancer

Services

Development of radiopharmaceutical therapies, Precision cancer treatment using actinium-225, Manufacturing of pharmaceutical products, Clinical trial capabilities, Drug discovery and development

Target Customers

Cancer patients, Oncologists, Healthcare providers, Research institutions, Pharmaceutical companies

Taxonomy

Radiopharmaceuticals, Cancer Treatment, Targeted Therapies, Radioisotopes, Alpha Particles, Actinium-225, Oncology Drug Development, Pipeline Development, Bristol Myers Squibb, Innovative Cancer Solutions, Radiopharmaceutical Leadership, Patient Outcomes, Clinical Advancement, Cancer Treatment Revolution

Business Model

B2B, B2D

Revenue Model

Product Sales, Licensing

Frequently Asked Questions

Top alternatives to RayzeBio include Exelixis, NiKang Therapeutics Inc., Arcellx, Crossbow Therapeutics, Inc, Alterome Therapeutics, Inc. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to RayzeBio based on industry overlap, target customers, and business model.

Targeted innovative radiopharmaceuticals for cancer

Don't just read about them. Follow them.

BounceWatch watches RayzeBio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

RayzeBio Profile Exelixis Alternatives NiKang Therapeutics Inc. Alternatives Arcellx Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at RayzeBio on 28 Jan 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.